Limited pelvic lymphadenectomy using the sentinel lymph node procedure in patients with localised prostate carcinoma: A pilot study

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 6, 2005, Pages 635-640

  Brenot Rossi, Isabelle ^a   Bastide, Cyril ^b   Garcia, Stephane ^b   Dumas, Stephane ^a   Esterni, Benjamin ^a   Pasquier, Jacques ^a   Rossi, Dominique ^b  

^a INSTITUT PAOLI CALMETTES   (France)

^b AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Lymph node dissection; Lymphoscintigraphy; Prostate cancer; Prostatic carcinoma; Sentinel lymph node

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; RHENIUM TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; CLINICAL TRIAL; HUMAN; ILIAC VEIN; INTERNAL ILIAC ARTERY; LYMPH NODE METASTASIS; LYMPHATIC DRAINAGE; LYMPHOID TISSUE; MALE; PELVIS LYMPHADENECTOMY; PROSTATE CARCINOMA; SCINTIGRAPHY; SENTINEL LYMPH NODE; STATISTICAL ANALYSIS; SURGICAL TECHNIQUE;

AGED; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PELVIS; PROSTATIC NEOPLASMS; SENTINEL LYMPH NODE BIOPSY; SURGERY, COMPUTER-ASSISTED; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME;

EID: 21244453033     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1750-3     Document Type: Article

References (20)

1. Clark T, Parekh DJ, Coockson MS, Chang SS, Smith ER, Wells N, et al. Randomized prospective evaluation of extended versus limited lymph node dissection in patients with clinically localized prostate cancer. J Urol 2003;169: 145-8.
2. El-Galley RE, Keane TE, Petros JA, Sanders WH, Clarke HS, Cotsonis GA, et al. Evaluation of staging lymphadenectomy in prostate cancer. Urology 1998;52:663-7.
3. Bader P, Burkhard FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 2002;168:514-8.
4. Burkhard FC, Bader P, Schneider E, Markwalder R, Studer UE. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur Urol 2002;42:84-92.
5. Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002; 167:1681-6.
6. Campbell SC, Klein EA, Levin HS, Piedmonte MR. Open pelvic lymph node dissection for prostate cancer: a reassessment. Urology 1995;46:352-5.
7. Haese A, Epstein JI, Huland H, Partin AW. Validation of a biopsy-based pathologic algorithm for predicting lymph node metastases in patients with clinically localized prostate carcinoma. Cancer 2002;95:1016-21.
8. Pisansky TM, Zincke H, Suman VJ, Bostwick DG, Earle JD, Oesterling JE. Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens. Int J Radiat Oncol Biol Phys 1996; 34:33-9.
9. Ghavamian R, Blute ML, Bergstralh EJ, Slezak J, Zincke H. Comparison of clinical non palpable PSA detected (cT1c) versus palpable (cT2) prostate cancers in patients undergoing radical retropubic prostatectomy. Urology 1999;54:105-10.
10. Harisinghani MG, Barentsz J, Hahn P, Deserno WM, Tabatabaei S, Hulsbergen van de Kaa C, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348:2491-9.
11. American Joint Committee on Cancer 2002. Cancer staging handbook: TNM classification of malignant tumors. 6th ed. Berlin Heidelberg New York: Springer; 2002.
12. Sobin LH, Fleming ID. TNM classification of malignant tumors. 5th ed. 1997. Union Internationale contre le Cancer and the American Joint Committee on Cancer. Cancer 1997; 80:1803-4.
13. Brossner C, Ringhofer H, Hernady T, Kuber W, Madersbacher S, Pycha A. Lymphatic drainage of prostatic transition and peripheral zones visualised on a three dimensional workstation. Urology 2001;57:389-93.
14. Brossner C, Ringhofer H, Schatzl G, Maderbacher S, Powischer G, Kuber W. Sacral distribution of prostatic lymph nodes visualized on spiral computed tomography with three-dimensional reconstruction. BJU Int 2002;89:44-7.
15. Raghavaiah NV, Jordan WP. Prostatic lymphography. J Urol 1979;121:178-81.
16. Zuckier LS, Finkelstein M, Kreutzer ER, Stone PL, Freed SZ, Bard RH, et al. Technetium-99m antinomy sulphide colloid lymphoscintigraphy of the prostate by direct transrectal injection. Med Nucl Commun 1990;11:589-96.
17. Wawroschek F, Vogt H, Weckermann D, Wagner T, Hamm M, Harzmann R. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 2001;166(5):1715-9.
18. Wawroschek F, Wagner T, Hamm M, Weckermann D, Vogt H, Märkl B, et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol 2003;43(2):132-6.
19. Wawroschek F, Vogt H, Wengenmair H, Weckermann D, Hamm M, Keil M, et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases. Urol Intl 2003;70(4):303-10.
20. Takashima H, Egawa M, Imao T, Fukuda M, Yokoyama K, Namiki M. Validity of sentinel lymph node concept for patients with prostate cancer. J Urol 2004;171:2268-71.